FDA letter monthly archive

FDA Letters Issued in March 2012

Name: FDA Letters Issued in March 2012
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in March 2012. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Chelsea Therapeutics, Inc. (Mar 28, 2012)
FDA's complete response letter contains source-text evidence related to Clinical efficacy and substantial evidence, Labeling, packaging, and proprietary name, Safety and adverse events, Chemistry, manufacturing, and controls. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedMar 28, 2012
US FDA• NORTHERA

Complete Response Letter Chelsea Therapeutics, Inc. (Mar 28, 2012)